MassIVE MSV000081456

Partial Public

GNPS - HILIC LC-MS/MS of sputum from CF patients treated with tobramycin

Description

LC-MS/MS HILIC Analysis. The methanol metabolite extracts from three patients for the oxygen experiments with Aspergillus reads (CF157, CF146 and CF353) and three without (CF178, CF243, CF69) were additionally used for the HILIC chromatography analysis to more efficiently detect tobramycin and its metabolites. These samples were extracted further using a water/methanol 4:1 extract solution for 5 min, followed by centrifugation to pellet debris prior to mass spectrometry analysis. The analysis was conducted on a Vanquish UHPLC (Thermo Fisher Scientific, Waltham, MA) connected to Orbitrap (Q Exactive, Thermo Fisher Scientific, Waltham, MA) mass spectrometer equipped with HESI-II probe source. The separation was conducted using a 100 x 2.1 mm Kinetex 1.7 ?M, HILIC, 100Å column (Phenomenex, Torrance, CA). The column was held at 40°C during the analysis. The mobile phases used were: A 99.9 % HPLC grade water 0.1% formic acid (Thermo Fisher Scientific, Optima LC/MS), and B 99.9% HPLC grade acetonitrile 0.1% formic acid (Fisher Scientific, Optima LC/MS). Following gradient steps were used: 0-1 min 100% B, 1-4 min 100-90% B, 4-14 min 90-0% B, 14.0-14.9 min 100% A, 14.9-17.0 min 100% B. Flow rate was set at 0.350 mL/min. For the MS acquisition, following settings were used: positive ion mode, Spray voltage of 3500 V, ion source temperature of 270°C, Capillary temperature 250°C, S-lens RF level of 50 Hz, Sheath gas (N2) pressure of 45 psi, Auxiliary gas pressure (N2) of 10 psi, and Aux gas heater temp. at 410°C. 5 ?l of the sample was injected. The data were acquired in a data dependent acquisition (DDA) mode with both MS1 full scan (150-1500 m/z) and up to 5 MS2 scans of the most abundant ions per duty cycle. The resolution of Orbitrap mass analyzer was set at 30,000. The MS2 precursor selection window was set to 1.5 m/z with 0.5 m/z offset. The normalized collision energy was set to stepwise increase from 20 to 30 to 40 units with z = 1 as default charge state. The MS2 acquisition was set to be automatically triggered at the apex of a peak within 2 to 15 s from their first occurrence with the dynamic exclusion time of 5 s. [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Cystic fibrosis ; HILIC ; Sputum

Contact

Principal Investigators:
(in alphabetical order)
Pieter Dorrestein, University of California San Diego, USA
Submitting User: lfnothias

Publications

Quinn RA, Comstock W, Zhang T, Morton JT, da Silva R, Tran A, Aksenov A, Nothias LF, Wangpraseurt D, Melnik AV, Ackermann G, Conrad D, Klapper I, Knight R, Dorrestein PC.
Niche partitioning of a pathogenic microbiome driven by chemical gradients.
Sci Adv. 2018 Sep;4(9):eaau1908. Epub 2018 Sep 26.

Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


GNPS content goes here (MSV000081456 [task=56f6d2f53e774297a84df347175dfbb8])
Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.